Item 1B. Unresolved Staff Comments
Item 1B. Unresolved Staff Comments .
None.
58
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
I tem 2. Properties.
The following is a summary of Cooper's principal facilities as of October 31, 2021. We generally lease our office and operations facilities but own several manufacturing and research and development facilities, including 226,342 square feet in the United Kingdom, 164,946 square feet in Costa Rica, 63,787 square feet in Denmark, 76,778 square feet in New York and 33,630 square feet in Texas. Our lease agreements expire at various dates through the year 2045. We believe our properties are suitable and adequate for our businesses.
Location Approximate
Square Feet
Operations
AMERICAS
United States:
California 129,540 Executive offices; CooperVision research and development and administrative offices; CooperSurgical manufacturing and office
New York 423,175 CooperVision manufacturing, sales / commercial offices, distribution and administrative offices; CooperSurgical manufacturing, office and distribution
Connecticut 301,962 CooperSurgical manufacturing, sales / commercial offices, distribution, research and development and administrative offices
Texas 36,113 CooperSurgical sales / commercial offices, manufacturing and office
Puerto Rico 527,285 CooperVision manufacturing, research and development and distribution
Costa Rica 168,002 CooperVision and CooperSurgical manufacturing and offices
Brazil 16,580 CooperVision sales / commercial offices and distribution
Canada 25,154 CooperVision sales / commercial offices and CooperSurgical office
Other Americas 114,197 CooperVision manufacturing, sales / commercial offices and distribution; CooperSurgical sales / commercial offices and laboratory
EMEA
United Kingdom 797,647 CooperVision manufacturing, sales / commercial offices, distribution, research and development and administrative offices; CooperSurgical sales / commercial offices, manufacturing, and genetics lab
Hungary 330,269 CooperVision manufacturing, distribution and sales / commercial offices
Belgium 280,067 CooperVision distribution
Spain 180,058 CooperVision distribution, sales / commercial offices and administrative offices; CooperSurgical sales / commercial offices
Denmark 63,787 CooperSurgical manufacturing, marketing and administrative offices
Other EMEA 286,128 CooperVision sales / commercial offices; CooperSurgical manufacturing, sales / commercial offices and distribution
ASIA PACIFIC
Japan 87,588 CooperVision sales / commercial, distribution and administrative offices; CooperSurgical laboratory, sales, marketing and distribution
Australia 27,005 CooperVision sales / commercial, distribution and administrative offices; CooperSurgical sales / distribution offices
Other Asia Pacific 96,780 CooperVision and CooperSurgical sales / commercial offices and distribution
59
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 3. Legal Proceedings.
Information regarding legal proceedings is included in Note 12. Contingencies of the Consolidated Financial Statements.
Item 4. Mine Safety Disclosures.
Not applicable.
60
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
PART II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.